Short Interest in Sonova Holding (OTCMKTS:SONVY) Decreases By 77.6%

Sonova Holding (OTCMKTS:SONVY) saw a large decline in short interest during the month of January. As of January 30th, there was short interest totaling 8,247 shares, a decline of 77.6% from the January 15th total of 36,769 shares. Based on an average trading volume of 47,269 shares, the short-interest ratio is presently 0.2 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 47,269 shares, the short-interest ratio is presently 0.2 days.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Zacks Research lowered shares of Sonova from a “hold” rating to a “strong sell” rating in a research report on Tuesday, December 9th. Royal Bank Of Canada raised Sonova to a “moderate buy” rating in a research note on Tuesday, November 18th. Finally, BNP Paribas Exane assumed coverage on shares of Sonova in a report on Monday, October 20th. They issued an “underperform” rating for the company. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, three have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.

Sonova Trading Down 0.2%

Shares of OTCMKTS SONVY traded down $0.09 during midday trading on Tuesday, hitting $53.40. 21,076 shares of the stock traded hands, compared to its average volume of 23,045. Sonova has a one year low of $47.55 and a one year high of $68.76. The firm has a 50-day moving average of $52.89 and a two-hundred day moving average of $54.48. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.24 and a quick ratio of 0.91.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.